One healthcare player that insiders are snapping up a huge amount of stock in here is Tenet Healthcare (THC - Get Report), which mainly operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers and related health care facilities. Insiders are buying this stock into solid strength, since shares have spiked higher by 26% in 2013.
Tenet Healthcare has a market cap of $4.07 billion and an enterprise value of $9.8 billion. This stock trades at a reasonable valuation, with a forward price-to-earnings of 15.19. Its estimated growth rate for this year is 2.3%, and for next year it's pegged at 52.5%. This is not a cash-rich company, since the total cash position on its balance sheet is $82 million and its total debt is a whopping $5.82 billion.
A beneficial owner just bought 248,910 shares, or about $9.9 million worth of stock, at $39.79 per share. This same beneficial owner also just bought 644,582 shares, or about $25.74 million worth of stock, at $39.78 per share.
From a technical perspective, THC is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending over the last two months, with shares moving lower from its high of $48.48 to its recent low of $38.71 a share. During that downtrend, shares of THC have been making mostly lower highs and lower lows, which is bearish technical price action.
If you're bullish on THC, then I would look for long-biased trades as long as this stock is trending above its recent low of $38.71, and then once it breaks out above some near-term overhead resistance $41.32 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 1.91 million shares. If that breakout hits soon, then THC will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day of $42.99 to its 200-day at $43.50 a share. Any high-volume move above those levels will then give THC a chance to tag its next major overhead resistance levels at $44.17 to $46 a share.